SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GelTex Pharmaceuticals (GELX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: EACarl who wrote (105)3/5/1999 1:44:00 PM
From: H. Bradley Toland, Jr.   of 127
 
Ditto your comments about the shorts. Frankly, I'm kind of amazed as 3 million shares out of 17 million with only 11 to 12 million shares in the "float" is a very substantial short position.

Also, in addition to Geltex saying they are pleased with the early results for Renagel, yesterday both Henri Termeer (CEO of Genzyme) and the CFO of Genzyme stated that Renagel sales are ahead of plan and that the anecdotal comments they are getting from the field are quite favorable.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News